Feasibility of early sirolimus cessation post non-myeloablative transplantation in adult patients with severe sickle cell disease

Saved in:

Bibliographic Details
Published in:	Bone marrow transplantation (Basingstoke) Vol. 57; no. 2; pp. 319 - 322
Main Authors:	Damlaj, Moussab, Alahmari, Bader, Alaskar, Ahmed, Alhejazi, Ayman, Alsadi, Husam, Shehab-Eddine, Inaam, Alghamdi, Abdulrahman, Almashaqbeh, Walid, Alshobaki, Heba, Mahasneh, Isam, Alotaibi, Ashwaq, Alanazi, Tahany, Balili, Maybelle, Quarshi, Mohammed, Ahmed, Mazin, Alzahrani, Mohsen
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 01-02-2022 Nature Publishing Group
Subjects:	692/308/575 692/499 Adult Anemia, Sickle Cell - therapy Cell Biology Correspondence Feasibility Studies Graft vs Host Disease Hematology Hematopoietic Stem Cell Transplantation Humans Internal Medicine Medicine Medicine & Public Health Public Health Rapamycin Sickle cell disease Sirolimus - therapeutic use Stem Cells Transplantation Transplantation Conditioning
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1
ISSN:	0268-3369 1476-5365
DOI:	10.1038/s41409-021-01548-8